Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ion Beam ApplicationsIOBCF +4.23%80 3-Year Revenue Growth Rate is 19.60% as of Jun. 2026, which is 717% above its 10-year median of 2.40. GuruFocus rates IOBCF with a GF Score™ of 80/100 and a GF Value™ of $18.71 (Fairly Valued). The stock has 7 warning signs investors should review. Among 758 Medical Devices & Instruments companies, Ion Beam Applications ranks better than 83.77% on this metric.
During the past 12 months, Ion Beam Applications's average Revenue per Share Growth Rate was 4.80% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 19.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 15.60% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 7.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Ion Beam Applications was 36.60% per year. The lowest was -17.70% per year. And the median was 2.40% per year.
Ion Beam Applications (OTCPK:IOBCF) 3-Year Revenue Growth Rate Explanation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
Ion Beam Applications 3-Year Revenue Growth Rate Related Terms
IOBCF vs ABT, SYK, MDT: 3-Year Revenue Growth Rate Comparison
For the Medical Devices subindustry, Ion Beam Applications's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ion Beam Applications 3-Year Revenue Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ion Beam Applications's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where Ion Beam Applications's 3-Year Revenue Growth Rate falls into.
Ion Beam Applications 3-Year Revenue Growth Rate Calculation
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
What does a 3-Year Revenue Growth Rate of 19.60% mean?
Ion Beam Applications (IOBCF) has a 3-Year Revenue Growth Rate of 19.60% as of Jun. 2026. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for Ion Beam Applications and its competitors. This is 717% above median its historical median of 2.40. According to the industry distribution chart, Ion Beam Applications ranks #123 out of 758 companies in the Medical Devices & Instruments industry, placing it in the top 16.2%.
Is Ion Beam Applications' 3-Year Revenue Growth Rate too high?
Ion Beam Applications' current 3-Year Revenue Growth Rate of 19.60% is 717% above median its 10-year median of 2.40. The Medical Devices & Instruments industry median 3-Year Revenue Growth Rate is 3.75. Ion Beam Applications' value of 19.60% is 422.7% above this industry median. Based on the distribution chart, Ion Beam Applications ranks #123 out of 758 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Ion Beam Applications has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ion Beam Applications' 3-Year Revenue Growth Rate compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Ion Beam Applications ranks #123 out of 758 companies for 3-Year Revenue Growth Rate. This places Ion Beam Applications in the top 16% of its industry — outperforming the majority of peers. The industry median 3-Year Revenue Growth Rate is 3.75. Ion Beam Applications' value of 19.60% is 422.7% above this benchmark. While the company's 10-year median is 2.40 vs. the industry median of 3.75, Ion Beam Applications has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Revenue Growth Rate for a Medical Devices & Instruments company?
The median 3-Year Revenue Growth Rate among Medical Devices & Instruments companies is 3.75, based on 758 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Revenue Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Revenue Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ion Beam Applications's current 3-Year Revenue Growth Rate of 19.60% is 422.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Revenue Growth Rate mean?
A high 3-Year Revenue Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Revenue Growth Rate is the 3-year average growth rate of Revenue per share. View historical data for Ion Beam Applications and its competitors. For the Medical Devices & Instruments industry, the median 3-Year Revenue Growth Rate is 3.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ion Beam Applications's current 3-Year Revenue Growth Rate is 19.60%, which is 717% above median its own 10-year median of 2.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ion Beam Applications stock overvalued right now?
Based on GuruFocus' analysis, Ion Beam Applications (IOBCF) is currently considered Fairly Valued. The stock's GF Value™ is $18.71, compared to a current price of $18.50 — trading 1.1% below its estimated fair value. The current 3-Year Revenue Growth Rate is 19.60%, which is 717% above median its 10-year median of 2.40 and 422.7% above the Medical Devices & Instruments industry median of 3.75. Ion Beam Applications' overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Revenue Growth Rate calculated?
3-Year Revenue Growth Rate is calculated from a company's financial statements. For Ion Beam Applications (IOBCF), the current 3-Year Revenue Growth Rate is 19.60% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ion Beam Applications (IOBCF) Overvalued in 2026?
Based on GuruFocus' analysis, Ion Beam Applications stock appears to be undervalued.
The current stock price of $18.50 is trading 1.1% below its estimated GF Value™ of $18.71.
GuruFocus considers Ion Beam Applications to be Fairly Valued.
Key valuation signals for IOBCF:
3-Year Revenue Growth Rate: 19.60% (717% above median its 10-year median of 2.40)
GF Value™: $18.71 vs. price of $18.50 (1.1% below fair value)
Industry Position: 422.7% above the Medical Devices & Instruments median (#123 of 758)
No single metric tells the full story. See the IOBCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in three segments: IBA Clinical, including Proton Therapy and Dosimetry; IBA Technologies; and IBA Corporate. Proton therapy and other accelerators contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, China, Germany, and India.
80GF Score
Get the complete analysis for IOBCF
3-Year Revenue Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IOBCF has been successfully added to your 
